{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:05:59Z","timestamp":1791450359434,"version":"4.3.3"},"reference-count":53,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T00:00:00Z","timestamp":1392076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"},{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["mBio"],"published-print":{"date-parts":[[2014,2,28]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Cryptococcosis is an infectious disease of global significance for which new therapies are needed. Repurposing previously developed drugs for new indications can expedite the translation of new therapies from bench to beside. Here, we characterized the anti-cryptococcal activity and antifungal mechanism of estrogen receptor antagonists related to the breast cancer drugs tamoxifen and toremifene. Tamoxifen and toremifene are fungicidal and synergize with fluconazole and amphotericin B<jats:italic>in vitro<\/jats:italic>. In a mouse model of disseminated cryptococcosis, tamoxifen at concentrations achievable in humans combines with fluconazole to decrease brain burden by ~1 log<jats:sub>10<\/jats:sub>. In addition, these drugs inhibit the growth of<jats:named-content content-type=\"genus-species\">Cryptococcus neoformans<\/jats:named-content>within macrophages, a niche not accessible by current antifungal drugs. Toremifene and tamoxifen directly bind to the essential EF hand protein calmodulin, as determined by thermal shift assays with purified<jats:named-content content-type=\"genus-species\">C. neoformans<\/jats:named-content>calmodulin (Cam1), prevent Cam1 from binding to its well-characterized substrate calcineurin (Cna1), and block Cna1 activation. In whole cells, toremifene and tamoxifen block the calcineurin-dependent nuclear localization of the transcription factor Crz1. A large-scale chemical genetic screen with a library of<jats:named-content content-type=\"genus-species\">C. neoformans<\/jats:named-content>deletion mutants identified a second EF hand-containing protein, which we have named calmodulin-like protein 1 (CNAG_05655), as a potential target, and further analysis showed that toremifene directly binds Cml1 and modulates its ability to bind and activate Cna1. Importantly, tamoxifen analogs (idoxifene and methylene-idoxifene) with increased calmodulin antagonism display improved anti-cryptococcal activity, indicating that calmodulin inhibition can be used to guide a systematic optimization of the anti-cryptococcal activity of the triphenylethylene scaffold.<\/jats:p><jats:p><jats:bold>IMPORTANCE<\/jats:bold>Worldwide, cryptococcosis affects approximately 1 million people annually and kills more HIV\/AIDS patients per year than tuberculosis. The gold standard therapy for cryptococcosis is amphotericin B plus 5-flucytosine, but this regimen is not readily available in regions where resources are limited and where the burden of disease is highest. Herein, we show that molecules related to the breast cancer drug tamoxifen are fungicidal for<jats:italic>Cryptococcus<\/jats:italic>and display a number of pharmacological properties desirable for an anti-cryptococcal drug, including synergistic fungicidal activity with fluconazole<jats:italic>in vitro<\/jats:italic>and<jats:italic>in vivo<\/jats:italic>, oral bioavailability, and activity within macrophages. We have also demonstrated that this class of molecules targets calmodulin as part of their mechanism of action and that tamoxifen analogs with increased calmodulin antagonism have improved anti-cryptococcal activity. Taken together, these results indicate that tamoxifen is a pharmacologically attractive scaffold for the development of new anti-cryptococcal drugs and provide a mechanistic basis for its further optimization.<\/jats:p>","DOI":"10.1128\/mbio.00765-13","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T02:34:41Z","timestamp":1392172481000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":101,"title":["Estrogen Receptor Antagonists Are Anti-Cryptococcal Agents That Directly Bind EF Hand Proteins and Synergize with Fluconazole<i>In Vivo<\/i>"],"prefix":"10.1128","volume":"5","author":[{"given":"Arielle","family":"Butts","sequence":"first","affiliation":[{"name":"Department of Chemistry, University of Rochester, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy","family":"Koselny","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Rochester, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeissa","family":"Chabrier-Rosell\u00f3","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camile P.","family":"Semighini","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C. S.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biophysics, University of California-San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar","family":"Annadurai","sequence":"additional","affiliation":[{"name":"Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"DiDone","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Rochester, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Tabroff","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Rochester, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Wayne E.","family":"Childers","sequence":"additional","affiliation":[{"name":"Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magid","family":"Abou-Gharbia","sequence":"additional","affiliation":[{"name":"Moulder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Wellington","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Rochester, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Cardenas","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiten D.","family":"Madhani","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biophysics, University of California-San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Heitman","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian J.","family":"Krysan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Rochester, Rochester, New York, USA"},{"name":"Department of Microbiology\/Immunology, University of Rochester, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328322ffac"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2006.07.001"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00165-12"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/649858"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110404"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32832fa214"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/604716"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002870"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm030480f"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.2174\/156802612804547399"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00314-12"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1042\/bst0171038"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01564-08"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2011.31"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342040-00004"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709695104"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00039-10"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/34.6.1051"},{"key":"e_1_3_2_20_2","unstructured":"National Committee for Clinical Laboratory Standards . 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27\u2013MA2. National Committee for Clinical Laboratory Standards Wayne PA."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.1.163-194.2005"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.739-746.2000"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002800050852"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh108"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00158-11"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/315649"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm219"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0090-9556(25)07102-8","article-title":"Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient","volume":"19","author":"Robinson SP","year":"1991","unstructured":"RobinsonSP Langan-FaheySM JohnsonDA JordanVC . 1991. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab. Dispos. 19:36\u201343.","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.178301"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.147"},{"key":"e_1_3_2_31_2","first-page":"617","article-title":"Antitumor activity of a new antiestrogenic drug, toremifene (NK622) against human breast cancer xenografts in nude mice","volume":"20","author":"Kuroiwa S","year":"1993","unstructured":"KuroiwaS KoyamaM WatanabeN EkimotoH OhnishiY SaitoM MaruoK InabaM TashiroT YamoriT . 1993. Antitumor activity of a new antiestrogenic drug, toremifene (NK622) against human breast cancer xenografts in nude mice. Gan To Kagaku Ryoho 20:617\u2013623.","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.06.040"},{"key":"e_1_3_2_33_2","first-page":"2753","article-title":"Ca2(+)-dependent binding of tamoxifen to calmodulin isolated from bovine brain","volume":"50","author":"Lopes MC","year":"1990","unstructured":"LopesMC ValeMG CarvalhoAP . 1990. Ca2(+)-dependent binding of tamoxifen to calmodulin isolated from bovine brain. Cancer Res. 50:2753\u20132758.","journal-title":"Cancer Res."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2011.0390"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)01528-6"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025280"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.genet.35.102401.091302"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/25133"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.4.6.1079-1087.2005"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051403"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.11.24.3432"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1199"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.45.28366"},{"key":"e_1_3_2_44_2","first-page":"6274","article-title":"Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells","volume":"46","author":"Gulino A","year":"1986","unstructured":"GulinoA BarreraG VaccaA FarinaA FerrettiC ScrepantiI DianzaniMU FratiL . 1986. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. Cancer Res. 46:6274\u20136278.","journal-title":"Cancer Res."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)00186-4"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm9505472"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M303300200"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2002.03165.x"},{"key":"e_1_3_2_49_2","first-page":"471","article-title":"Targeting calcium homeostasis as a therapy of Chagas\u2019 disease and leishmanisis\u2014a review","volume":"28","author":"Benaim B","year":"2011","unstructured":"BenaimB GarciaCR . 2011. Targeting calcium homeostasis as a therapy of Chagas\u2019 disease and leishmanisis\u2014a review. Trop. Biomed. 28:471\u2013481.","journal-title":"Trop. Biomed."},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.07.046"},{"key":"e_1_3_2_51_2","volume-title":"Methods in yeast genetics","author":"Burke DJ","year":"2000","unstructured":"BurkeDJ DawsonD StearnsT . 2000. Methods in yeast genetics. CSHL Press, Woodbury, NY."},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-353"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-7-r63"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/19.2.185"}],"container-title":["mBio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mBio.00765-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mBio.00765-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T20:49:55Z","timestamp":1746132595000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/mBio.00765-13"}},"subtitle":[],"editor":[{"given":"Liise-anne","family":"Pirofski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2,28]]}},"alternative-id":["10.1128\/mBio.00765-13"],"URL":"https:\/\/doi.org\/10.1128\/mbio.00765-13","relation":{},"ISSN":["2161-2129","2150-7511"],"issn-type":[{"value":"2161-2129","type":"print"},{"value":"2150-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,28]]},"assertion":[{"value":"2013-09-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-12-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-02-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00765-13"}}